Home
About
Overview
Sharing Data
ORCID
Help
History (1)
RD3 loss dictates high-risk aggressive neuroblastoma and poor clinical outcomes.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
RD3 loss dictates high-risk aggressive neuroblastoma and poor clinical outcomes.
RD3 loss dictates high-risk aggressive neuroblastoma and poor clinical outcomes. Oncotarget. 2015 Nov 03; 6(34):36522-34.
View in:
PubMed
subject areas
Animals
Animals
Cell Line, Tumor
Cell Line, Tumor
Disease Progression
Disease Progression
Eye Proteins
Eye Proteins
Heterografts
Heterografts
Humans
Humans
Mice
Mice
Neuroblastoma
Neuroblastoma
Survival Analysis
Survival Analysis
Tissue Array Analysis
Tissue Array Analysis
Treatment Outcome
Treatment Outcome
authors with profiles
Natarajan Aravindan
Sheeja Aravindan